Pharmacoepidemiology and Benefit-Risk Management

PrimeVigilance’s multi–disciplinary team is led by Dr. Michael Forstner, Head of Pharmacoepidemiology and Risk Management.

As a well-known and respected expert in the design and implementation of evidence based studies, along with cutting-edge methods in both pharmacovigilance planning and risk management, PrimeVigilance is a unique industry partner.

PrimeVigilance’s researchers bring hundreds of years of experience from industry, regulatory authorities, and academia in all important therapeutic areas, as well as advanced degrees in medicine, pharmacoepidemiology, biostatistics, pharmacology, and public health to the table to provide expert advice in all areas of pharmacoepidemiology and pharmacovigilance benefit/risk management. PrimeVigilance can support you in specific short-term projects or through extended arrangements with dedicated experts on a long-term basis.

This site uses cookies to personalise and customise your experience. No cookies collect personal or sensitive information. By clicking “I Accept", you consent to cookies in accordance with our cookie policy.

Privacy Settings saved!
Privacy Settings

When you visit any web site, it may store or retrieve information on your browser, mostly in the form of cookies. Control your personal Cookie Services here.

In order to use this website we use the following technically required cookies
  • wordpress_test_cookie
  • wordpress_logged_in_
  • wordpress_sec

For perfomance reasons we use Cloudflare as a CDN network. This saves a cookie "__cfduid" to apply security settings on a per-client basis. This cookie is strictly necessary for Cloudflare's security features and cannot be turned off.
  • __cfduid

Decline all Services
Accept all Services